Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Zak

Showing results (61-70 of 84) with videos related to

Pageof 9
Sort By:
Antimicrobial Agents and Chemotherapy|December 15, 2022
Prophylactic Administration of the Monoclonal Antibody Adintrevimab Protects against SARS-CoV-2 in Hamster and Non-Human Primate Models of COVID-19Elizabeth E Zumbrun, Chengzi I Kaku, Lukas Dillinger, et al.
Viruses|December 23, 2023
SARS-CoV-2 Aerosol and Intranasal Exposure Models in FerretsElizabeth E Zumbrun, Samantha E Zak, Eric D Lee, et al.
Frontiers in Immunology|May 1, 2018
A Serum Circulating miRNA Signature for Short-Term Risk of Progression to Active Tuberculosis Among Household ContactsFergal J Duffy, Ethan Thompson, Katrina Downing, et al.
Methods (San Diego, Calif.)|January 16, 2021
Bisindolylmaleimide IX: A novel anti-SARS-CoV2 agent targeting viral main protease 3CLpro demonstrated by virtual screening pipeline and in-vitro validation assaysYash Gupta, Dawid Maciorowski, Samantha E Zak, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 16, 2012
Merck Ad5/HIV induces broad innate immune activation that predicts CD8⁺ T-cell responses but is attenuated by preexisting Ad5 immunityDaniel E Zak, Erica Andersen-Nissen, Eric R Peterson, et al.
Cell Host & Microbe|November 3, 2020
Ultra-low Dose Aerosol Infection of Mice with Mycobacterium tuberculosis More Closely Models Human TuberculosisCourtney R Plumlee, Fergal J Duffy, Benjamin H Gern, et al.
Plos Medicine|April 17, 2019
Discovery and validation of a prognostic proteomic signature for tuberculosis progression: A prospective cohort studyAdam Penn-Nicholson, Thomas Hraha, Ethan G Thompson, et al.
Plos Medicine|July 19, 2019
Correction: Discovery and validation of a prognostic proteomic signature for tuberculosis progression: A prospective cohort studyAdam Penn-Nicholson, Thomas Hraha, Ethan G Thompson, et al.
The Journal of Experimental Medicine|August 19, 2015
Interleukin 27R regulates CD4+ T cell phenotype and impacts protective immunity during Mycobacterium tuberculosis infectionEgidio Torrado, Jeffrey J Fountain, Mingfeng Liao, et al.
Plos One|December 1, 2022
Neutrophil degranulation, NETosis and platelet degranulation pathway genes are co-induced in whole blood up to six months before tuberculosis diagnosisStuart Meier, James A Seddon, Elizna Maasdorp, et al.
Pageof 9

Showing results (61-70 of 84) with videos related to

Sort By:
Pageof 9
Antimicrobial Agents and Chemotherapy|December 15, 2022
Prophylactic Administration of the Monoclonal Antibody Adintrevimab Protects against SARS-CoV-2 in Hamster and Non-Human Primate Models of COVID-19Elizabeth E Zumbrun, Chengzi I Kaku, Lukas Dillinger, et al.
Viruses|December 23, 2023
SARS-CoV-2 Aerosol and Intranasal Exposure Models in FerretsElizabeth E Zumbrun, Samantha E Zak, Eric D Lee, et al.
Frontiers in Immunology|May 1, 2018
A Serum Circulating miRNA Signature for Short-Term Risk of Progression to Active Tuberculosis Among Household ContactsFergal J Duffy, Ethan Thompson, Katrina Downing, et al.
Methods (San Diego, Calif.)|January 16, 2021
Bisindolylmaleimide IX: A novel anti-SARS-CoV2 agent targeting viral main protease 3CLpro demonstrated by virtual screening pipeline and in-vitro validation assaysYash Gupta, Dawid Maciorowski, Samantha E Zak, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 16, 2012
Merck Ad5/HIV induces broad innate immune activation that predicts CD8⁺ T-cell responses but is attenuated by preexisting Ad5 immunityDaniel E Zak, Erica Andersen-Nissen, Eric R Peterson, et al.
Cell Host & Microbe|November 3, 2020
Ultra-low Dose Aerosol Infection of Mice with Mycobacterium tuberculosis More Closely Models Human TuberculosisCourtney R Plumlee, Fergal J Duffy, Benjamin H Gern, et al.
Plos Medicine|April 17, 2019
Discovery and validation of a prognostic proteomic signature for tuberculosis progression: A prospective cohort studyAdam Penn-Nicholson, Thomas Hraha, Ethan G Thompson, et al.
Plos Medicine|July 19, 2019
Correction: Discovery and validation of a prognostic proteomic signature for tuberculosis progression: A prospective cohort studyAdam Penn-Nicholson, Thomas Hraha, Ethan G Thompson, et al.
The Journal of Experimental Medicine|August 19, 2015
Interleukin 27R regulates CD4+ T cell phenotype and impacts protective immunity during Mycobacterium tuberculosis infectionEgidio Torrado, Jeffrey J Fountain, Mingfeng Liao, et al.
Plos One|December 1, 2022
Neutrophil degranulation, NETosis and platelet degranulation pathway genes are co-induced in whole blood up to six months before tuberculosis diagnosisStuart Meier, James A Seddon, Elizna Maasdorp, et al.
Pageof 9